rebastinib and paclitaxel for advanced/metastatic ovarian cancer
Published 2 years ago • 450 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
7:15
rebastinib plus paclitaxel shows encouraging anti-tumor activity in endometrial cancer
-
3:27
icon8: outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
25:20
ovarian cancer 2021: recent advance in treatment
-
2:36
managing toxicities in advanced ovarian cancer
-
0:52
investigating toxicities with lenvatinib plus paclitaxel in ovarian and endometrial cancers
-
1:12
where is ovarian cancer treatment headed?
-
3:45
treatment options for ovarian cancer
-
5:33
recurrent advanced ovarian cancer: case impressions
-
0:42
dr. zsiros discusses pembrolizumab triplet in recurrent ovarian cancer
-
4:20
advanced ovarian cancer: case perspectives
-
3:05
esmo 2021: key trials for breast cancer
-
5:19
abiraterone in patients with recurrent epithelial ovarian cancer
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
4:08
ovarian cancer – an introduction, with dr. paul sabbatini
-
1:01:42
new developments in ovarian cancer surgery
-
1:24
innovations in ovarian cancer treatment: parp inhibitors
-
1:34
dr. leath discusses surgical cytoreduction in ovarian cancer
-
5:59
case 2: newly diagnosed ovarian cancer, gbrca-mutated